Cargando…

TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells

Left ventricular hypertrophy is an independent risk factor in diabetic patients. TGR5 is shown to express in hearts, but its functional role in diabetes-induced cardiac hypertrophy remained unclear. The current study investigated the role of TGR5 on high glucose-induced hypertrophy of H9C2 cells. Af...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Kai-Chun, Chang, Wei-Ting, Kuo, Feng Yu, Chen, Zhih-Cherng, Li, Yingxiao, Cheng, Juei-Tang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403401/ https://www.ncbi.nlm.nih.gov/pubmed/30842472 http://dx.doi.org/10.1038/s41598-019-40002-0

Ejemplares similares

Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models
por: Cheng, Kai-Chun, et al.
Publicado: (2018)

Identification of Andrographolide as an Agonist of Bile Acid TGR5 Receptor in a Cell Line to Demonstrate the Reduction in Hyperglycemia in Type-1 Diabetic Rats
por: Li, Yingxiao, et al.
Publicado: (2023)

Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
por: Cheng, Kai-Chun, et al.
Publicado: (2018)

Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals
por: Li, Yingxiao, et al.
Publicado: (2017)

TGR5 Expression Is Associated with Changes in the Heart and Urinary Bladder of Rats with Metabolic Syndrome
por: Hsu, Chia-Chen, et al.
Publicado: (2021)

Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats
por: Kuo, Feng Yu, et al.
Publicado: (2020)

Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
por: Chang, Wei-Ting, et al.
Publicado: (2016)

Doxorubicin-Induced Cardiac Toxicity Is Mediated by Lowering of Peroxisome Proliferator-Activated Receptor δ Expression in Rats
por: Chen, Zhih-Cherng, et al.
Publicado: (2013)

Etanercept Ameliorates Cardiac Fibrosis in Rats with Diet-Induced Obesity
por: Hsu, Chia-Chen, et al.
Publicado: (2021)

Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
por: Lo, Shih-Hsiang, et al.
Publicado: (2016)

Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats
por: Niu, Ho-Shan, et al.
Publicado: (2016)

Increase of ATP-sensitive potassium (K(ATP)) channels in the heart of type-1 diabetic rats
por: Chen, Zhih-Cherng, et al.
Publicado: (2012)

Oral glucose tolerance test in diabetes, the old method revisited
por: Kuo, Feng Yu, et al.
Publicado: (2021)

Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy
por: Han, Sha-sha, et al.
Publicado: (2015)

Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility
por: Ku, Po-Ming, et al.
Publicado: (2011)

Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate
por: Chen, Zhih-Cherng, et al.
Publicado: (2013)

Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ–STAT3 Signaling in Type 1-Like Diabetic Rats
por: Lo, Shih-Hsiang, et al.
Publicado: (2017)

miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts
por: Chang, Wei-Ting, et al.
Publicado: (2022)

Activation of TGR5 Ameliorates Streptozotocin-Induced Cognitive Impairment by Modulating Apoptosis, Neurogenesis, and Neuronal Firing
por: Mu, Ronghao, et al.
Publicado: (2022)

Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
por: Cheng, Kai-Chun, et al.
Publicado: (2020)

Bolus Injection of Liraglutide Raises Plasma Glucose in Normal Rats by Activating Glucagon-like Peptide 1 Receptor in the Brain
por: Hsu, Chia-Chen, et al.
Publicado: (2022)

TGR5, Not Only a Metabolic Regulator
por: Guo, Cong, et al.
Publicado: (2016)

TGR5 Signaling in Hepatic Metabolic Health
por: Holter, Marlena M., et al.
Publicado: (2020)

Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway
por: Wang, Hui‐Bo, et al.
Publicado: (2019)

Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl(4)-Induced Liver Cirrhosis
por: Li, Ping-Chun, et al.
Publicado: (2012)

TGR5 Activation Ameliorates Mitochondrial Homeostasis via Regulating the PKCδ/Drp1-HK2 Signaling in Diabetic Retinopathy
por: Zhang, Meng-Yuan, et al.
Publicado: (2022)

Amelioration of High Fructose-Induced Cardiac Hypertrophy by Naringin
por: Park, Jung Hyun, et al.
Publicado: (2018)

The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats
por: Wang, Lin-Yu, et al.
Publicado: (2017)

Telmisartan Activates PPARδ to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice
por: Li, Yingxiao, et al.
Publicado: (2017)

TGR5 expression in normal kidney and renal neoplasms
por: Zhao, Chaohui Lisa, et al.
Publicado: (2018)

TGR5 regulates portal perfusion pressure of the liver
por: Ghallab, Ahmed
Publicado: (2019)

Assessment of subclinical cardiac dysfunction by speckle-tracking echocardiography among people living with human immunodeficiency virus
por: Liao, Chia-Te, et al.
Publicado: (2023)

FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice
por: Iracheta‐Vellve, Arvin, et al.
Publicado: (2018)

Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation
por: Xue, Ruicong, et al.
Publicado: (2017)

Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy
por: Wang, Zhao-Peng, et al.
Publicado: (2019)

Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia
por: Li, Hong, et al.
Publicado: (2017)

Central anorexigenic actions of bile acids are mediated by TGR5
por: Perino, Alessia, et al.
Publicado: (2021)

Identification of the Role of TGR5 in the Regulation of Leydig Cell Homeostasis
por: Holota, Hélène, et al.
Publicado: (2022)

Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats
por: Tang, Liqun, et al.
Publicado: (2020)

Compound K attenuates hyperglycemia by enhancing glucagon-like peptide-1 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism
por: Tian, Fengyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9m4fdulclu6cqmgh91340f3uam